#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
CRP.3000518.AP009048.4153663_4154296.461	CRP.3000518.AP009048.4153663_4154296.461	1	0	539	2552	CRP	633	633	99.53	CRP.l15.c4.ctg.1	1502	125.3	0	.	p	.	0	K29T	NONSYN	85	87	AAG	443	445	ACG	210;211;206	A;C;G	208;210;206	.	CRP is a global regulator that represses MdtEF multidrug efflux pump expression.;CRP
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	0	.	p	.	0	G394S	NONSYN	1180	1182	GGC	1134	1136	AGC	180;177;179	A,G;G;C	114,66;176;179	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	1	SNP	p	L121Q	0	.	.	361	363	CTG	315	317	CTG	437;437;439	C;T;G	434;427;435	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:L121Q:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	1	SNP	p	Q125K	0	.	.	373	375	CAG	327	329	CAG	440;438;441	C;A;G	437;428;438	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	1	SNP	p	Q125R	0	.	.	373	375	CAG	327	329	CAG	440;438;441	C;A;G	437;428;438	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125R:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	1	SNP	p	Q125E	0	.	.	373	375	CAG	327	329	CAG	440;438;441	C;A;G	437;428;438	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Q125E:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	1	SNP	p	Y161C	0	.	.	481	483	TAC	435	437	TAC	446;441;440	T;A,C;C	443;432,1;432	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161C:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	1	SNP	p	Y161N	0	.	.	481	483	TAC	435	437	TAC	446;441;440	T;A,C;C	443;432,1;432	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161N:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	1	SNP	p	Y161D	0	.	.	481	483	TAC	435	437	TAC	446;441;440	T;A,C;C	443;432,1;432	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:Y161D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	1	SNP	p	G317D	0	.	.	949	951	GGC	903	905	GGC	457;447;442	G;G,C;C	452;445,1;440	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:G317D:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	1	SNP	p	A376S	0	.	.	1126	1128	GCA	1080	1082	GCA	336;336;341	G,A;C;A,G	326,1;330;334,1	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376S:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	1	SNP	p	A376V	0	.	.	1126	1128	GCA	1080	1082	GCA	336;336;341	G,A;C;A,G	326,1;330;334,1	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:A376V:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	1	SNP	p	E379K	0	.	.	1135	1137	GAA	1089	1091	GAA	337;338;337	G;A;A	333;332;328	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531:1:1:E379K:.:Sequence variants of Escherichia coli elongation factor Tu that confer resistance to kirromycin	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	0	HET	.	.	.	T81G	.	81	81	T	35	35	T	199	T,G	43,53	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	0	HET	.	.	.	C216T	.	216	216	C	170	170	C	387	C,T	208,176	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	0	HET	.	.	.	C954T	.	954	954	C	908	908	C	413	C,T	180,226	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	0	HET	.	.	.	C99T	.	99	99	C	53	53	C	213	C,T	66,85	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	0	HET	.	.	.	C69T	.	69	69	C	23	23	C	215	C,T	33,46	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	0	HET	.	.	.	T135C	.	135	135	T	89	89	T	255	T,C	126,121	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	1139	99.56	Escherichia_coli_EF_Tu.l15.c17.ctg.1	1446	339.1	0	HET	.	.	.	T78A	.	78	78	T	32	32	T	204	T,A	43,52	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	120	100.0	Escherichia_coli_EF_Tu.l15.c17.ctg.2	363	95.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	Escherichia_coli_EF_Tu.3003368.AH002539.2.1760_2945.3531	1	1	679	7530	Escherichia_coli_EF_Tu	1185	117	98.29	Escherichia_coli_EF_Tu.l15.c17.ctg.3	356	34.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli EF-Tu mutants conferring resistance to kirromycin
Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666	1	1	539	2758	Escherichia_coli_mutant_1	1359	1359	99.85	Escherichia_coli_mutant_1.l15.c30.ctg.1	2092	97.0	1	SNP	p	E448K	1	E448K	NONSYN	1342	1344	GAA	1744	1746	AAA	67;66;65	A;A;A	67;66;65	Escherichia_coli_mutant.3003889.HG738867.2233288_2234647.3666:1:1:E448K:.:Mutations to the active importer GlpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant GlpT conferring resistance to fosfomycin
Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667	1	1	27	4346	Escherichia_coli_mutant	1392	1392	99.43	Escherichia_coli_mutant.l15.c30.ctg.1	2071	153.6	1	SNP	p	E350Q	0	.	.	1048	1050	GAA	1389	1391	GAA	186;187;188	G;A;A	184;186;187	Escherichia_coli_mutant.3003890.HG738867.2934266_2935658.3667:1:1:E350Q:.:Mutations to the active importer UhpT, which is involved with the uptake of many phosphorylated sugars, confer resistance to fosfomycin by reducing import of the drug into the bacteria.	Escherichia coli mutant UhpT conferring resistance to fosfomycin
H_NS.3000676.NC_002695.1737553_1737967.218	H_NS.3000676.NC_002695.1737553_1737967.218	1	0	27	964	H_NS	414	414	99.03	H_NS.l15.c30.ctg.1	1159	61.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	H-NS;H-NS is a histone-like protein involved in global gene regulation in Gram-negative bacteria. It is a repressor of the membrane fusion protein genes acrE, mdtE, and emrK as well as nearby genes of many RND-type multidrug exporters.
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	A1136G	SNP	1136	1136	A	95	95	G	632	G,A	627,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	T1138C	SNP	1138	1138	T	97	97	C	636	C	635	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	T1142C	SNP	1142	1142	T	101	101	C	646	C,A	637,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	C1170T	SNP	1170	1170	C	129	129	T	810	T	800	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	T1220C	SNP	1220	1220	T	179	179	C	810	C	803	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	T1245C	SNP	1245	1245	T	204	204	C	688	C	680	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	G1253A	SNP	1253	1253	G	212	212	A	599	A	596	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	G1256A	SNP	1256	1256	G	215	215	A	553	A	550	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	C1258A	SNP	1258	1258	C	217	217	A	546	A	541	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	G1266T	SNP	1266	1266	G	225	225	T	548	T	539	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	T1267C	SNP	1267	1267	T	226	226	C	552	C	546	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	T1275C	SNP	1275	1275	T	234	234	C	549	C,T,A	542,1,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	G1276A	SNP	1276	1276	G	235	235	A	552	A,C	545,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	A1281G	SNP	1281	1281	A	240	240	G	551	G,T	547,2	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	T1283C	SNP	1283	1283	T	242	242	C	564	C	562	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	G1288T	SNP	1288	1288	G	247	247	T	595	T	589	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	A1296G	SNP	1296	1296	A	255	255	G	676	G,A	672,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	T1299G	SNP	1299	1299	T	258	258	G	666	G	664	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	A1300T	SNP	1300	1300	A	259	259	T	671	T	668	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	C1356T	SNP	1356	1356	C	315	315	T	901	T	894	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	A1358G	SNP	1358	1358	A	317	317	G	887	G	879	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	T1368C	SNP	1368	1368	T	327	327	C	845	C	841	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	G1370A	SNP	1370	1370	G	329	329	A	829	A	821	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	C1406.	DEL	1406	1406	C	364	364	C	566	C	560	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	.1409C	INS	1409	1409	T	368	368	C	514	C	510	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	C1431A	SNP	1431	1431	C	390	390	A	396	A	392	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	C1432A	SNP	1432	1432	C	391	391	A	406	A,G	401,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	A1441G	SNP	1441	1441	A	400	400	G	468	G	463	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	T1464C	SNP	1464	1464	T	423	423	C	441	C	434	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	G1473T	SNP	1473	1473	G	432	432	T	587	T	580	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	A1475G	SNP	1475	1475	A	434	434	G	602	G	596	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	0	.	n	.	0	A1548T	SNP	1548	1548	A	507	507	T	665	T,C	663,2	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	509	91.96	Pasteurella_multocida_16S.l15.c30.ctg.3	544	685.3	1	SNP	n	C1194G	0	.	.	1194	1194	C	153	153	C	878	C	875	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252:0:0:C1194G:.:Point mutations in the helix 34 region of 16S rRNA of Pasteurella multocida can confer resistance to spectinomycin	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c30.ctg.5	183	125.2	0	.	n	.	0	C990G	SNP	990	990	C	58	58	G	110	G	105	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c30.ctg.5	183	125.2	0	.	n	.	0	T1002A	SNP	1002	1002	T	70	70	A	114	A	111	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c30.ctg.5	183	125.2	0	.	n	.	0	A1004G	SNP	1004	1004	A	72	72	G	115	G	114	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c30.ctg.5	183	125.2	0	.	n	.	0	C1011T	SNP	1011	1011	C	79	79	T	113	T	112	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c30.ctg.5	183	125.2	0	.	n	.	0	C1023A	SNP	1023	1023	C	91	91	A	160	A	158	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c30.ctg.5	183	125.2	0	.	n	.	0	T1024A	SNP	1024	1024	T	92	92	A	170	A	166	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c30.ctg.5	183	125.2	0	.	n	.	0	T1041G	SNP	1041	1041	T	109	109	G	203	G	202	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	183	92.9	Pasteurella_multocida_16S.l15.c30.ctg.5	183	125.2	0	.	n	.	0	A1042T	SNP	1042	1042	A	110	110	T	199	T	199	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	185	92.47	Pasteurella_multocida_16S.l15.c30.ctg.6	185	187.0	0	.	n	.	0	C990G	SNP	990	990	C	60	60	G	129	G	119	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	185	92.47	Pasteurella_multocida_16S.l15.c30.ctg.6	185	187.0	0	.	n	.	0	T1002A	SNP	1002	1002	T	72	72	A	123	A	122	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	185	92.47	Pasteurella_multocida_16S.l15.c30.ctg.6	185	187.0	0	.	n	.	0	A1003C	SNP	1003	1003	A	73	73	C	120	C	120	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	185	92.47	Pasteurella_multocida_16S.l15.c30.ctg.6	185	187.0	0	.	n	.	0	G1008C	SNP	1008	1008	G	78	78	C	114	C	114	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	185	92.47	Pasteurella_multocida_16S.l15.c30.ctg.6	185	187.0	0	.	n	.	0	C1011T	SNP	1011	1011	C	81	81	T	106	T	106	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	185	92.47	Pasteurella_multocida_16S.l15.c30.ctg.6	185	187.0	0	.	n	.	0	T1012C	SNP	1012	1012	T	82	82	C	107	C	107	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	185	92.47	Pasteurella_multocida_16S.l15.c30.ctg.6	185	187.0	0	.	n	.	0	C1023A	SNP	1023	1023	C	92	92	A	140	A	139	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	185	92.47	Pasteurella_multocida_16S.l15.c30.ctg.6	185	187.0	0	.	n	.	0	.1025G	INS	1025	1025	T	95	95	G	153	G,C	151,1	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	185	92.47	Pasteurella_multocida_16S.l15.c30.ctg.6	185	187.0	0	.	n	.	0	T1041G	SNP	1041	1041	T	111	111	G	186	G	184	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	Pasteurella_multocida_16S.3003493.NC_002663.1.341427_342977.3252	0	0	548	9914	Pasteurella_multocida_16S	1551	185	92.47	Pasteurella_multocida_16S.l15.c30.ctg.6	185	187.0	0	.	n	.	0	A1042T	SNP	1042	1042	A	112	112	T	189	T	187	.	Pasteurella multocida 16S rRNA mutation conferring resistance to spectinomycin
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	2876	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1794	118.2	0	.	p	.	0	H2R	NONSYN	4	6	CAT	409	411	CGT	148;152;152	C;G;T	146;150;152	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	2876	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1794	118.2	0	.	p	.	0	V30I	NONSYN	88	90	GTC	493	495	ATC	153;155;154	A;T;C	147;155;153	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrB.3003583.NC_007779.4336858_4337950.2119	PmrB.3003583.NC_007779.4336858_4337950.2119	1	0	539	2876	PmrB_1	1092	1092	99.08	PmrB_1.l15.c4.ctg.1	1794	118.2	0	.	p	.	0	D283G	NONSYN	847	849	GAC	1252	1254	GGC	104;105;101	G;G;C	103;103;100	.	Histidine protein kinase sensor Lipid A modification gene; part of a two-component system involved in polymyxin resistance that senses high extracellular Fe(2+);PmrB
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	4610	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2288	148.5	0	.	p	.	0	R8S	NONSYN	22	24	AGA	360	362	AGC	94;95;105	A;G;C	94;93;104	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	4610	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2288	148.5	0	.	p	.	0	I142L	NONSYN	424	426	ATA	762	764	CTA	158;158;156	C;T;A	157;157;155	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	4610	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2288	148.5	0	.	p	.	0	R315Q	NONSYN	943	945	CGA	1281	1283	CAA	193;194;196	C;A;A	192;192;194	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	4610	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2288	148.5	0	.	p	.	0	D348G	NONSYN	1042	1044	GAT	1380	1382	GGT	229;229;230	G;G,C;T,C,G	228;228,1;222,1,1	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrC.3003576.AP009048.4338624_4340268.2117	PmrC.3003576.AP009048.4338624_4340268.2117	1	0	539	4610	PmrC	1644	1644	99.15	PmrC.l15.c4.ctg.1	2288	148.5	0	.	p	.	0	I538V	NONSYN	1612	1614	ATT	1950	1952	GTT	210;206;203	G;T;T	210;205;202	.	PmrC mediates the modification of Lipid A by the addition of 4-amino-4-deoxy-L-arabinose (L-Ara4N) and phosphoethanolamine, resulting in a less negative cell membrane and decreased binding of polymyxin B.;PmrC
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	2024	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1951	76.9	0	.	p	.	0	A125E	NONSYN	373	375	GCA	738	740	GAA	122;122;121	G;A,G;A	120;118,1;120	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	2024	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1951	76.9	0	.	p	.	0	M185T	NONSYN	553	555	ATG	918	920	ACC	81;76;76	A;C;C	79;76;76	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	2024	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1951	76.9	0	.	p	.	0	S225T	NONSYN	673	675	TCC	1038	1040	ACT	79;76;76	A;C;T	78;75;76	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrE.3003577.U00096.2098446_2099613.2116	PmrE.3003577.U00096.2098446_2099613.2116	1	0	539	2024	PmrE	1167	1167	96.83	PmrE.l15.c30.ctg.1	1951	76.9	0	.	p	.	0	T355I	NONSYN	1063	1065	ACC	1428	1430	ATC	39;40;40	A;T;C	38;40;40	.	PmrE is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin;PmrE
PmrF.3003578.U00096.2367070_2368039.2115	PmrF.3003578.U00096.2367070_2368039.2115	1	0	27	2692	PmrF	969	969	99.38	PmrF.l15.c30.ctg.1	1629	121.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	PmrF;PmrF is required for the synthesis and transfer of 4-amino-4-deoxy-L-arabinose (Ara4N) to Lipid A, which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin
aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	aada1.manually_added_NC_007384_WP_001206315.1_4110458_4111246	1	0	27	2052	aad-	789	789	100.0	aad-.l15.c4.ctg.1	1555	97.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_007384.1 Shigella sonnei Ss046, complete genome
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	7680	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3721	152.4	0	.	p	.	0	T85I	NONSYN	253	255	ACC	554	556	ATC	179;179;181	A;T;C	179;179;180	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrD.3000491.NC_007779.2586250_2589364.664	acrD.3000491.NC_007779.2586250_2589364.664	1	0	539	7680	acrD	3114	3114	99.1	acrD.l15.c4.ctg.1	3721	152.4	0	.	p	.	0	Q656K	NONSYN	1966	1968	CAA	2267	2269	AAG	148;151;153	A;A;G	148;151;152	.	acrD;AcrD is an aminoglycoside efflux pump expressed in E. coli. Its expression can be induced by indole, and is regulated by baeRS and cpxAR.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	3228	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1717	137.8	0	.	p	.	0	A22V	NONSYN	64	66	GCC	329	331	GTC	90;91;91	G;T;C	90;90;91	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrE.3000499.U00096.3413863_3415021.333	acrE.3000499.U00096.3413863_3415021.333	1	0	539	3228	acrE	1158	1158	98.79	acrE.l15.c4.ctg.1	1717	137.8	0	.	p	.	0	S269C	NONSYN	805	807	AGC	1070	1072	TGC	217;214;212	T;G;C	216;213;210	.	acrE;AcrE is a membrane fusion protein, similar to AcrA.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	7146	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3343	158.3	0	.	p	.	0	S46trunc	TRUNC	136	136	T	555	555	T	96	T	95	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	7146	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3343	158.3	0	.	p	.	0	G148D	NONSYN	442	444	GGC	861	863	GAC	208;208;208	G;A;C	204;207;205	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	7146	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3343	158.3	0	.	p	.	0	F240L	NONSYN	718	720	TTT	1137	1139	TTA	140;140;139	T;T;A	134;139;138	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	7146	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3343	158.3	0	.	p	.	0	D301N	NONSYN	901	903	GAT	1320	1322	AAT	156;156;156	A;A;T	155;155;154	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrF.3000502.U00096.3415032_3418137.700	acrF.3000502.U00096.3415032_3418137.700	1	0	528	7146	acrF	3105	2598	98.5	acrF.l15.c4.ctg.1	3343	158.3	0	.	p	.	0	L563fs	FSHIFT	1687	1687	T	2107	2107	T	208	T	207	.	acrF;AcrF is a inner membrane transporter, similar to AcrB.
acrR.3003807.NC_000913.3.485760_486408.3575	acrR.3003807.NC_000913.3.485760_486408.3575	1	1	27	1942	acrR_2	648	648	99.54	acrR_2.l15.c4.ctg.1	1374	104.4	1	SNP	p	R45C	0	.	.	133	135	CGC	509	511	CGC	180;178;177	C;G;C	180;178;177	acrR.3003807.NC_000913.3.485760_486408.3575:1:1:R45C:.:AcrR is a repressor of the AcrAB-TolC multidrug efflux complex. AcrR mutations result in high level antibiotic resistance. The mutations associated with this model are specific to E. coli.	Escherichia coli acrR mutants resulting in antibiotic resistance
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	1636	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1194	100.8	0	.	p	.	0	L34F	NONSYN	100	102	CTC	375	377	TTC	128;130;130	T;T;C	127;129;129	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
acrS.3000656.U00096.3412802_3413465.551	acrS.3000656.U00096.3412802_3413465.551	1	0	539	1636	acrS	663	663	98.64	acrS.l15.c30.ctg.1	1194	100.8	0	.	p	.	0	E122G	NONSYN	364	366	GAG	639	641	GGG	146;141;141	G;G;G	146;141;141	.	acrS;AcrS is a repressor of the AcrAB efflux complex and is associated with the expression of AcrEF. AcrS is believed to regulate a switch between AcrAB and AcrEF efflux.
adiY.3003828.NC_000913.3.4337167_4337929.3591	adiY.3003828.NC_000913.3.4337167_4337929.3591	1	0	539	2132	adiY	762	762	99.61	adiY.l15.c4.ctg.1	1337	116.8	0	.	p	.	0	V136L	NONSYN	406	408	GTT	607	609	CTT	233;235;233	C;T;T	232;234;233	.	adiY is a DNA-binding transcriptional activator of the adi system. Implicated in arginine-dependent acid resistance in Escherichia coli.;adiY
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	7276	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3331	161.2	0	.	p	.	0	T618A	NONSYN	1852	1854	ACA	2209	2211	GCA	258;258;264	G;C;A	256;255;260	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	7276	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3331	161.2	0	.	p	.	0	A705T	NONSYN	2113	2115	GCC	2470	2472	ACC	223;225;225	A;C;C	200;222;220	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
alaS.3003830.NC_000913.3.2819380_2822011.3592	alaS.3003830.NC_000913.3.2819380_2822011.3592	1	0	539	7276	alaS	2631	2631	98.86	alaS.l15.c30.ctg.1	3331	161.2	0	.	p	.	0	V808A	NONSYN	2422	2424	GTC	2779	2781	GCC	204;202;210	G;C;C	204;197;209	.	alanyl-tRNA synthetase conferring resistance to novobiocin in Escherichia coli;aminocoumarin resistant alaS
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	4434	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2245	139.3	0	.	p	.	0	G37A	NONSYN	109	111	GGT	313	315	GCT	100;100;104	G;C;T	97;99;103	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	4434	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2245	139.3	0	.	p	.	0	D77E	NONSYN	229	231	GAT	433	435	GAG	104;101;106	G;A;G	104;100;105	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	4434	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2245	139.3	0	.	p	.	0	Y89C	NONSYN	265	267	TAC	469	471	TGC	116;114;120	T;G;C	115;112;119	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	4434	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2245	139.3	0	.	p	.	0	I150V	NONSYN	448	450	ATT	652	654	GTT	125;126;126	G;T;T	124;126;126	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	4434	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2245	139.3	0	.	p	.	0	R200H	NONSYN	598	600	CGC	802	804	CAC	137;134;133	C;A;C	136;132;133	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	4434	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2245	139.3	0	.	p	.	0	T295M	NONSYN	883	885	ACG	1087	1089	ATG	182;181;180	A;T;G	175;172;170	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
arnA.3002985.U00096.2368038_2370021.355	arnA.3002985.U00096.2368038_2370021.355	1	0	539	4434	arnA_1	1983	1983	98.29	arnA_1.l15.c30.ctg.1	2245	139.3	0	.	p	.	0	H627R	NONSYN	1879	1881	CAC	2083	2085	CGC	156;146;146	C;G;C	154;144;145	.	arnA;arnA modifies lipid A with 4-amino-4-deoxy-L-arabinose (Ara4N) which allows gram-negative bacteria to resist the antimicrobial activity of cationic antimicrobial peptides and antibiotics such as polymyxin. arnA is found in E. coli and P. aeruginosa.
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	1844	bacA	822	822	98.54	bacA.l6.c30.ctg.1	1536	88.8	0	.	p	.	0	S221T	NONSYN	661	663	AGC	1033	1035	ACC	106;106;104	A;C;C	105;106;104	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
bacA.3002986.U00096.3203309_3204131.36	bacA.3002986.U00096.3203309_3204131.36	1	0	539	1844	bacA	822	822	98.54	bacA.l6.c30.ctg.1	1536	88.8	0	.	p	.	0	P225S	NONSYN	673	675	CCG	1045	1047	TCG	113;114;115	T;C;G	112;114;115	.	bacA is a gene that recycles undecaprenyl pyrophosphate during cell wall biosynthesis which confers resistance to bacitracin;bacA
baeR.3000828.NC_007779.2166412_2167135.676	baeR.3000828.NC_007779.2166412_2167135.676	1	0	27	1754	baeR	723	723	97.79	baeR.l15.c4.ctg.1	1439	89.7	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	baeR;BaeR is a response regulator that promotes the expression of MdtABC and AcrD efflux complexes.
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	2706	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	2025	98.4	0	.	p	.	0	Q376K	NONSYN	1126	1128	CAA	1391	1393	AAA	72;74;73	A;A;A	72;72;73	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	2706	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	2025	98.4	0	.	p	.	0	G380E	NONSYN	1138	1140	GGG	1403	1405	GAG	66;66;66	G;A;G	65;66;65	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	2706	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	2025	98.4	0	.	p	.	0	R382H	NONSYN	1144	1146	CGC	1409	1411	CAC	68;68;69	C;A;C	68;67;69	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
baeS.3000829.AP009048.2165012_2166416.608	baeS.3000829.AP009048.2165012_2166416.608	1	0	539	2706	baeS	1404	1404	98.86	baeS.l15.c4.ctg.1	2025	98.4	0	.	p	.	0	D400E	NONSYN	1198	1200	GAT	1463	1465	GAG	72;71;71	G;A;G	71;71;71	.	BaeS is a sensor kinase in the BaeSR regulatory system. While it phosphorylates BaeR to increase its activity, BaeS is not necessary for overexpressed BaeR to confer resistance.;baeS
cpxA.3000830.NC_002695.4903561_4904935.605	cpxA.3000830.NC_002695.4903561_4904935.605	1	0	27	3592	cpxA	1374	1374	98.91	cpxA.l6.c30.ctg.1	2083	127.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxA;CpxA is a membrane-localized sensor kinase that is activated by envelope stress. It starts a kinase cascade that activates CpxR, which promotes efflux complex expression.
cpxR.3000831.NC_002695.4904931_4905630.142	cpxR.3000831.NC_002695.4904931_4905630.142	1	0	27	2368	cpxR	699	699	99.43	cpxR.l15.c4.ctg.1	1343	131.3	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	cpxR;CpxR is a regulator that promotes acrD expression when phosphorylated by a cascade involving CpxA, a sensor kinase.
cysB.3003840.NC_000913.3.1333854_1334829.3604	cysB.3003840.NC_000913.3.1333854_1334829.3604	1	0	539	2226	cysB	975	975	99.28	cysB.l15.c4.ctg.1	1469	112.0	0	.	p	.	0	A146T	NONSYN	436	438	GCT	660	662	ACT	151;152;154	A;C;T	150;151;154	.	Positive regulator of gene expression in the cysteine regulon. cysB mutants confer resistance to novobiocin, an aminocoumarin antibiotic, in Escherichia coli.;aminocoumarin resistant cysB
dfrA1.3002854.NC_010410.3676915_3677389.140	dfrA1.3002854.NC_010410.3676915_3677389.140	1	0	27	1130	dfrA1_1	474	474	100.0	dfrA1_1.l15.c17.ctg.1	1218	68.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	dfrA1 is an integron-encoded dihydrofolate reductase found in Escherichia coli;dfrA1
emrA.3000027.AP009048.2810082_2811255.411	emrA.3000027.AP009048.2810082_2811255.411	1	0	539	3134	emrA	1173	1173	98.29	emrA.l6.c4.ctg.1	1800	128.9	0	.	p	.	0	I219V	NONSYN	655	657	ATC	949	951	GTC	185;181;183	G;T;C	183;177;182	.	EmrA is a membrane fusion protein, providing an efflux pathway with EmrB and TolC between the inner and outer membranes of E. coli, a Gram-negative bacterium.;emrA
emrB.3000074.U00096.2812615_2814154.20	emrB.3000074.U00096.2812615_2814154.20	1	0	539	3972	emrB	1539	1539	99.74	emrB.l6.c30.ctg.1	2212	133.1	0	.	p	.	0	E197K	NONSYN	589	591	GAA	931	933	AAA	160;159;157	A;A,G;A,G	158;156,1;155,1	.	emrB is a translocase in the emrB -TolC efflux protein in E. coli. It recognizes substrates including carbonyl cyanide m-chlorophenylhydrazone (CCCP), nalidixic acid, and thioloactomycin.;emrB
emrD.3000309.GG749185.1.116812_118003.3622	emrD.3000309.GG749185.1.116812_118003.3622	1	0	539	2978	emrD	1191	1191	98.4	emrD.l15.c4.ctg.1	1880	116.1	0	.	p	.	0	G209S	NONSYN	625	627	GGC	875	877	AGC	194;193;186	A;G;C	192;191;184	.	EmrD is a multidrug transporter from the Major Facilitator Superfamily (MFS) primarily found in Escherichia coli. EmrD couples efflux of amphipathic compounds with proton import across the plasma membrane.;emrD
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	539	164	emrE_1	333	333	92.49	emrE_1.l6.c4.ctg.1	485	19.4	0	.	p	.	0	I100V	NONSYN	298	300	ATT	319	321	GTC	9;9;9	G;T;C	9;9;9	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrE.3000264.NC_007779.567537_567870.260	emrE.3000264.NC_007779.567537_567870.260	1	0	539	164	emrE_1	333	333	92.49	emrE_1.l6.c4.ctg.1	485	19.4	0	.	p	.	0	T108A	NONSYN	322	324	ACA	343	345	GCA	7;7;7	G;C;A	7;7;7	.	EmrE is a small multidrug transporter that functions as a homodimer and that couples the efflux of small polyaromatic cations from the cell with the import of protons down an electrochemical gradient. EmrE is found in E. coli and P. aeruginosa.;emrE
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	2638	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1659	117.4	0	.	p	.	0	K176R	NONSYN	526	528	AAG	792	794	AGG	103;101;101	A;G;G	103;99;99	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrK.3000206.D78168.536_1592.173	emrK.3000206.D78168.536_1592.173	1	0	539	2638	emrK	1056	1056	98.2	emrK.l15.c30.ctg.1	1659	117.4	0	.	p	.	0	N306D	NONSYN	916	918	AAC	1182	1184	GAC	115;119;126	G;A;C	115;119;125	.	emrK is a membrane fusion protein that is a homolog of EmrA. Together with the inner membrane transporter EmrY and the outer membrane channel TolC, it mediates multidrug efflux.;emrK
emrR.3000516.NC_000913.3.2810769_2811300.3621	emrR.3000516.NC_000913.3.2810769_2811300.3621	1	0	27	1852	emrR	531	531	100.0	emrR.l15.c4.ctg.1	1323	103.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrR;EmrR is a negative regulator for the EmrAB-TolC multidrug efflux pump in E. coli. Mutations lead to EmrAB-TolC overexpression.
emrY.3000254.D78168.1591_3130.65	emrY.3000254.D78168.1591_3130.65	1	0	27	3654	emrY	1539	1539	99.81	emrY.l15.c4.ctg.1	2261	118.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	emrY;emrY is a multidrug transport that moves substrates across the inner membrane of the Gram-negative E. coli. It is a homolog of emrB.
evgA.3000832.NC_002695.3211891_3212506.208	evgA.3000832.NC_002695.3211891_3212506.208	1	0	539	1664	evgA	615	615	99.19	evgA.l15.c4.ctg.1	1324	92.1	0	.	p	.	0	Q62L	NONSYN	184	186	CAG	574	576	CTG	173;162;158	C;T;G	170;161;155	.	evgA;EvgA, when phosphorylated, is a positive regulator for efflux protein complexes emrKY and mdtEF. While usually phosphorylated in a EvgS dependent manner, it can be phosphorylated in the absence of EvgS when overexpressed.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	T38I	NONSYN	112	114	ACA	484	486	ATA	136;133;131	A;T;A	135;133;130	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	L42V	NONSYN	124	126	CTA	496	498	GTA	134;135;135	G;T;A	134;135;134	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	A93T	NONSYN	277	279	GCG	649	651	ACG	144;145;138	A;C;G	142;145;137	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	A114E	NONSYN	340	342	GCA	712	714	GAA	130;132;131	G;A;A	130;131;131	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	T127A	NONSYN	379	381	ACT	751	753	GCT	94;93;94	G;C;T	94;93;93	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	N133D	NONSYN	397	399	AAT	769	771	GAT	90;93;95	G;A;T	89;92;94	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	P162S	NONSYN	484	486	CCA	856	858	TCA	104;107;105	T;C;A	104;107;105	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	H205Q	NONSYN	613	615	CAC	985	987	CAG	121;124;124	C;A;G,T	121;123;123,1	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	I251V	NONSYN	751	753	ATT	1123	1125	GTT	104;104;103	G;T;T	103;102;102	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	N303D	NONSYN	907	909	AAT	1279	1281	GAT	56;51;51	G;A;T	56;51;51	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	S359N	NONSYN	1075	1077	AGC	1447	1449	AAT	60;61;58	A;A;T	60;61;58	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	I366L	NONSYN	1096	1098	ATA	1468	1470	TTA	55;55;55	T;T;A	55;55;53	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	Q433K	NONSYN	1297	1299	CAG	1669	1671	AAA	93;93;91	A;A;A	93;91;90	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	N678H	NONSYN	2032	2034	AAT	2404	2406	CAT	133;132;134	C;A;T	131;131;134	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	N696H	NONSYN	2086	2088	AAT	2458	2460	CAT	135;136;136	C;A;T	135;135;135	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	K702R	NONSYN	2104	2106	AAA	2476	2478	AGA	138;138;132	A;G;A	137;136;130	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	K707N	NONSYN	2119	2121	AAG	2491	2493	AAT	141;140;141	A;A;T	138;139;139	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	A756S	NONSYN	2266	2268	GCC	2638	2640	TCC	133;134;136	T;C;C	133;134;136	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	S811I	NONSYN	2431	2433	AGT	2803	2805	ATT	147;145;145	A;T;T	146;144;145	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	E818D	NONSYN	2452	2454	GAA	2824	2826	GAT	143;144;143	G;A;T	143;144;142	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	G856V	NONSYN	2566	2568	GGT	2938	2940	GTT	128;128;127	G;T,G;T	128;127,1;126	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
evgS.3000833.U00096.2484373_2487967.178	evgS.3000833.U00096.2484373_2487967.178	1	0	539	7456	evgS	3594	3594	97.52	evgS.l15.c30.ctg.1	4331	127.5	0	.	p	.	0	Q951H	NONSYN	2851	2853	CAA	3223	3225	CAC	163;165;166	C;A;C	163;164;166	.	evgS;EvgS is a sensor protein that phosphorylates the regulatory protein EvgA.
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	2312	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1497	113.7	1	SNP	p	P64H	0	.	.	190	192	CCA	529	531	CCA	198;208;208	C;C;A,C	196;206;187,1	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64H:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	2312	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1497	113.7	1	SNP	p	P64A	0	.	.	190	192	CCA	529	531	CCA	198;208;208	C;C;A,C	196;206;187,1	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64A:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	2312	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1497	113.7	1	SNP	p	P64R	0	.	.	190	192	CCA	529	531	CCA	198;208;208	C;C;A,C	196;206;187,1	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64R:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	2312	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1497	113.7	1	SNP	p	P64S	0	.	.	190	192	CCA	529	531	CCA	198;208;208	C;C;A,C	196;206;187,1	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64S:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
folP.3003386.NC_007779.3323917_3324766.2056	folP.3003386.NC_007779.3323917_3324766.2056	1	1	27	2312	folP_1	849	849	99.29	folP_1.l15.c4.ctg.1	1497	113.7	1	SNP	p	P64L	0	.	.	190	192	CCA	529	531	CCA	198;208;208	C;C;A,C	196;206;187,1	folP.3003386.NC_007779.3323917_3324766.2056:1:1:P64L:.:Point mutations in Escherichia coli dihydropteroate synthase folP prevent sulfonamide antibiotics from inhibiting its role in folate synthesis, thus conferring sulfonamide resistance.	Escherichia coli sulfonamide resistant mutant folP
gadE.3003834.NC_000913.3.3658365_3658893.3597	gadE.3003834.NC_000913.3.3658365_3658893.3597	1	0	27	1510	gadE	528	528	100.0	gadE.l15.c17.ctg.1	1178	94.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	gadE;gadE is a DNA-binding transcriptional activator that regulates the expression of genes involved in acid resistance. It is required for the expression of gadA and gadBC.
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	564	gadW	729	666	94.29	gadW.l15.c17.ctg.1	909	46.1	0	.	p	.	0	L31V	NONSYN	91	93	CTG	31	33	GTG	3;3;3	G;T;G	3;3;3	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	564	gadW	729	666	94.29	gadW.l15.c17.ctg.1	909	46.1	0	.	p	.	0	D34E	NONSYN	100	102	GAT	40	42	GAG	4;4;4	G;A;G	4;4;4	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	564	gadW	729	666	94.29	gadW.l15.c17.ctg.1	909	46.1	0	.	p	.	0	L46P	NONSYN	136	138	CTG	76	78	CCG	13;12;12	C;C;G	13;12;12	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	564	gadW	729	666	94.29	gadW.l15.c17.ctg.1	909	46.1	0	.	p	.	0	E54D	NONSYN	160	162	GAA	100	102	GAT	28;28;28	G;A;T	28;28;28	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	564	gadW	729	666	94.29	gadW.l15.c17.ctg.1	909	46.1	0	.	p	.	0	I88M	NONSYN	262	264	ATA	202	204	ATG	23;23;23	A;T;G	23;23;23	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	564	gadW	729	666	94.29	gadW.l15.c17.ctg.1	909	46.1	0	.	p	.	0	Q89P	NONSYN	265	267	CAG	205	207	CCG	23;23;23	C;C;G	23;23;23	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	564	gadW	729	666	94.29	gadW.l15.c17.ctg.1	909	46.1	0	.	p	.	0	D100E	NONSYN	298	300	GAC	238	240	GAA	30;30;31	G;A;A	30;30;31	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	564	gadW	729	666	94.29	gadW.l15.c17.ctg.1	909	46.1	0	.	p	.	0	P101S	NONSYN	301	303	CCC	241	243	TCC	30;31;33	T;C;C	30;31;33	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	564	gadW	729	666	94.29	gadW.l15.c17.ctg.1	909	46.1	0	.	p	.	0	R102G	NONSYN	304	306	CGG	244	246	GGG	35;35;34	G;G;G	35;35;34	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	564	gadW	729	666	94.29	gadW.l15.c17.ctg.1	909	46.1	0	.	p	.	0	K110N	NONSYN	328	330	AAA	268	270	AAT	35;34;36	A;A;T	34;34;36	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadW.3003838.CP015085.1.2551711_2552440.3599	gadW.3003838.CP015085.1.2551711_2552440.3599	1	0	531	564	gadW	729	666	94.29	gadW.l15.c17.ctg.1	909	46.1	0	.	p	.	0	S234A	NONSYN	700	702	TCG	640	642	GCG	45;45;42	G;C;G	45;44;41	.	GadW is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance. GadW inhibits GadX-dependent activation. GadW clearly represses gadX and, in situations where GadX is missing, activates gadA and gadBC.;gadW
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1738	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1447	88.3	0	.	p	.	0	F53L	NONSYN	157	159	TTC	479	481	TTA	120;118;116	T;T;A	120;118;116	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1738	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1447	88.3	0	.	p	.	0	V79I	NONSYN	235	237	GTT	557	559	ATT	153;157;160	A;T;T	153;155;159	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1738	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1447	88.3	0	.	p	.	0	R246G	NONSYN	736	738	AGA	1058	1060	GGA	88;88;87	G;G;A	88;88;86	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gadX.3000508.NC_007779.3974604_3975429.615	gadX.3000508.NC_007779.3974604_3975429.615	1	0	539	1738	gadX	825	825	97.94	gadX.l15.c30.ctg.1	1447	88.3	0	.	p	.	0	S248P	NONSYN	742	744	TCG	1064	1066	CCG	85;85;86	C,A;C;G	83,2;85;86	.	GadX is an AraC-family regulator that promotes mdtEF expression to confer multidrug resistance.;gadX
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	7082	gyrA_7	2628	2628	98.71	gyrA_7.l6.c17.ctg.1	3398	154.0	0	.	p	.	0	D678E	NONSYN	2032	2034	GAC	2424	2426	GAA	177;170;169	G;A;A	175;168;163	.	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	7082	gyrA_7	2628	2628	98.71	gyrA_7.l6.c17.ctg.1	3398	154.0	1	SNP	p	S83L	0	.	.	247	249	TCG	639	641	TCG	178;177;174	T;C;G	176;176;172	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83L:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	7082	gyrA_7	2628	2628	98.71	gyrA_7.l6.c17.ctg.1	3398	154.0	1	SNP	p	S83I	0	.	.	247	249	TCG	639	641	TCG	178;177;174	T;C;G	176;176;172	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83I:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	7082	gyrA_7	2628	2628	98.71	gyrA_7.l6.c17.ctg.1	3398	154.0	1	SNP	p	S83W	0	.	.	247	249	TCG	639	641	TCG	178;177;174	T;C;G	176;176;172	gyrA.3003294.U00096.2336792_2339420.2052:1:1:S83W:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	7082	gyrA_7	2628	2628	98.71	gyrA_7.l6.c17.ctg.1	3398	154.0	1	SNP	p	D87H	0	.	.	259	261	GAC	651	653	GAC	173;174;172	G;A;C,A	169;170;169,1	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87H:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	7082	gyrA_7	2628	2628	98.71	gyrA_7.l6.c17.ctg.1	3398	154.0	1	SNP	p	D87Y	0	.	.	259	261	GAC	651	653	GAC	173;174;172	G;A;C,A	169;170;169,1	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87Y:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	7082	gyrA_7	2628	2628	98.71	gyrA_7.l6.c17.ctg.1	3398	154.0	1	SNP	p	D87G	0	.	.	259	261	GAC	651	653	GAC	173;174;172	G;A;C,A	169;170;169,1	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87G:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	7082	gyrA_7	2628	2628	98.71	gyrA_7.l6.c17.ctg.1	3398	154.0	1	SNP	p	D87N	0	.	.	259	261	GAC	651	653	GAC	173;174;172	G;A;C,A	169;170;169,1	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87N:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrA.3003294.U00096.2336792_2339420.2052	gyrA.3003294.U00096.2336792_2339420.2052	1	1	539	7082	gyrA_7	2628	2628	98.71	gyrA_7.l6.c17.ctg.1	3398	154.0	1	SNP	p	D87V	0	.	.	259	261	GAC	651	653	GAC	173;174;172	G;A;C,A	169;170;169,1	gyrA.3003294.U00096.2336792_2339420.2052:1:1:D87V:.:Point mutation of Escherichia coli gyrA resulted in the lowered affinity between fluoroquinolones and gyrA. Thus, conferring resistance	Escherichia coli gyrA conferring resistance to fluoroquinolones
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	6768	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3068	162.0	1	SNP	p	R136I	0	.	.	406	408	CGC	711	713	CGC	183;183;182	C;G;C	174;179;178	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136I:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	6768	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3068	162.0	1	SNP	p	R136L	0	.	.	406	408	CGC	711	713	CGC	183;183;182	C;G;C	174;179;178	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136L:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	6768	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3068	162.0	1	SNP	p	R136G	0	.	.	406	408	CGC	711	713	CGC	183;183;182	C;G;C	174;179;178	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136G:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	6768	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3068	162.0	1	SNP	p	R136H	0	.	.	406	408	CGC	711	713	CGC	183;183;182	C;G;C	174;179;178	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136H:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	6768	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3068	162.0	1	SNP	p	R136E	0	.	.	406	408	CGC	711	713	CGC	183;183;182	C;G;C	174;179;178	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136E:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	6768	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3068	162.0	1	SNP	p	R136S	0	.	.	406	408	CGC	711	713	CGC	183;183;182	C;G;C	174;179;178	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136S:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
gyrB.3003303.AP009048.3760295_3762710.2063	gyrB.3003303.AP009048.3760295_3762710.2063	1	1	27	6768	gyrB_1	2415	2415	99.05	gyrB_1.l15.c4.ctg.1	3068	162.0	1	SNP	p	R136C	0	.	.	406	408	CGC	711	713	CGC	183;183;182	C;G;C	174;179;178	gyrB.3003303.AP009048.3760295_3762710.2063:1:1:R136C:.:Point mutation in Escherichia coli resulting in aminocoumarin resistance	Escherichia coli gyrB conferring resistance to aminocoumarin
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	1248	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1228	74.5	0	.	p	.	0	A72P	NONSYN	214	216	GCG	526	528	CCG	108;104;105	C;C;G	107;103;105	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
kdpE.3003841.NC_000913.3.721055_721733.3608	kdpE.3003841.NC_000913.3.721055_721733.3608	1	0	539	1248	kdpE	678	678	98.23	kdpE.l15.c30.ctg.1	1228	74.5	0	.	p	.	0	T123A	NONSYN	367	369	ACC	679	681	GCC	77;78;76	G,C;C;C	73,1;74;74	.	kdpE is a transcriptional activator that is part of the two-component system KdpD/KdpE that is studied for its regulatory role in potassium transport and has been identified as an adaptive regulator involved in the virulence and intracellular survival of pathogenic bacteria. kdpE regulates a range of virulence loci through direct promoter binding.;kdpE
leuO.3003843.NC_000913.3.84367_85312.3607	leuO.3003843.NC_000913.3.84367_85312.3607	1	0	539	2712	leuO	945	945	99.26	leuO.l15.c30.ctg.1	1591	126.5	0	.	p	.	0	P9S	NONSYN	25	27	CCA	303	305	TCA	122;122;127	T;C;A,C	122;122;126,1	.	leuO;leuO, a LysR family transcription factor, exists in a wide variety of bacteria of the family Enterobacteriaceae and is involved in the regulation of as yet unidentified genes affecting the stress response and pathogenesis expression.
marA.3000263.NC_007779.1621287_1621671.579	marA.3000263.NC_007779.1621287_1621671.579	1	0	27	1038	marA	384	384	99.74	marA.l15.c4.ctg.1	1064	72.6	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	In the presence of antibiotic stress, E. coli overexpresses the global activator protein MarA, which besides inducing MDR efflux pump AcrAB, also down- regulates synthesis of the porin OmpF.;marA
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	846	marR	435	435	97.7	marR.l15.c4.ctg.1	1196	52.8	1	SNP	p	G103S	1	G103S	NONSYN	307	309	GGC	769	771	AGC	55;58;57	A;G;C	55;57;57	marR.3003378.U00096.1619119_1619554.2097:1:1:G103S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	846	marR	435	435	97.7	marR.l15.c4.ctg.1	1196	52.8	1	SNP	p	Y137H	1	Y137H	NONSYN	409	411	TAT	871	873	CAT	61;60;59	C;A;T	59;59;59	marR.3003378.U00096.1619119_1619554.2097:1:1:Y137H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	846	marR	435	435	97.7	marR.l15.c4.ctg.1	1196	52.8	1	SNP	p	V45E	0	.	.	133	135	GTG	595	597	GTG	129;127;127	G;T;G	128;127;126	marR.3003378.U00096.1619119_1619554.2097:1:1:V45E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	846	marR	435	435	97.7	marR.l15.c4.ctg.1	1196	52.8	1	SNP	p	I49S	0	.	.	145	147	ATC	607	609	ATC	143;145;144	A;T;C	142;143;144	marR.3003378.U00096.1619119_1619554.2097:1:1:I49S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	846	marR	435	435	97.7	marR.l15.c4.ctg.1	1196	52.8	1	SNP	p	A70T	0	.	.	208	210	GCA	670	672	GCA	95;95;97	G;C;A	94;94;97	marR.3003378.U00096.1619119_1619554.2097:1:1:A70T:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	846	marR	435	435	97.7	marR.l15.c4.ctg.1	1196	52.8	1	SNP	p	R73C	0	.	.	217	219	CGT	679	681	CGT	84;86;84	C;G;T	84;86;83	marR.3003378.U00096.1619119_1619554.2097:1:1:R73C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	846	marR	435	435	97.7	marR.l15.c4.ctg.1	1196	52.8	1	SNP	p	R73S	0	.	.	217	219	CGT	679	681	CGT	84;86;84	C;G;T	84;86;83	marR.3003378.U00096.1619119_1619554.2097:1:1:R73S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	846	marR	435	435	97.7	marR.l15.c4.ctg.1	1196	52.8	1	SNP	p	R77L	0	.	.	229	231	CGC	691	693	CGC	91;87;80	C;G;C	90;87;78	marR.3003378.U00096.1619119_1619554.2097:1:1:R77L:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	846	marR	435	435	97.7	marR.l15.c4.ctg.1	1196	52.8	1	SNP	p	R77C	0	.	.	229	231	CGC	691	693	CGC	91;87;80	C;G;C	90;87;78	marR.3003378.U00096.1619119_1619554.2097:1:1:R77C:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	846	marR	435	435	97.7	marR.l15.c4.ctg.1	1196	52.8	1	SNP	p	L78M	0	.	.	232	234	CTG	694	696	CTG	79;81;79	C;T;G	79;81;79	marR.3003378.U00096.1619119_1619554.2097:1:1:L78M:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	846	marR	435	435	97.7	marR.l15.c4.ctg.1	1196	52.8	1	SNP	p	R94H	0	.	.	280	282	CGC	742	744	CGC	66;67;66	C;G;C	64;66;64	marR.3003378.U00096.1619119_1619554.2097:1:1:R94H:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	846	marR	435	435	97.7	marR.l15.c4.ctg.1	1196	52.8	1	SNP	p	R94S	0	.	.	280	282	CGC	742	744	CGC	66;67;66	C;G;C	64;66;64	marR.3003378.U00096.1619119_1619554.2097:1:1:R94S:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
marR.3003378.U00096.1619119_1619554.2097	marR.3003378.U00096.1619119_1619554.2097	1	1	539	846	marR	435	435	97.7	marR.l15.c4.ctg.1	1196	52.8	1	SNP	p	V96E	0	.	.	286	288	GTA	748	750	GTA	57;58;58	G;T;A	56;57;57	marR.3003378.U00096.1619119_1619554.2097:1:1:V96E:.:MarR is a repressor of the mar operon marRAB, thus regulating the expression of marA, the activator of multidrug efflux pump AcrAB.	Escherichia coli marR mutant conferring antibiotic resistance
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	2188	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1898	84.4	0	.	p	.	0	S7F	NONSYN	19	21	TCC	338	340	TTC	60;63;65	T;T,C;C	60;62,1;65	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	2188	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1898	84.4	0	.	p	.	0	R36I	NONSYN	106	108	AGG	425	427	ATC	47;46;44	A;T;C	47;46;44	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	2188	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1898	84.4	0	.	p	.	0	E42A	NONSYN	124	126	GAA	443	445	GCC	46;46;46	G;C;C	43;45;45	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	2188	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1898	84.4	0	.	p	.	0	N43V	NONSYN	127	129	AAT	446	448	GTG	51;52;53	G;T;G	51;51;53	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	2188	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1898	84.4	0	.	p	.	0	E52D	NONSYN	154	156	GAG	473	475	GAT	49;46;48	G;A;T	49;45;48	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	2188	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1898	84.4	0	.	p	.	0	N59T	NONSYN	175	177	AAC	494	496	ACC	53;53;53	A;C;C	52;53;53	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	2188	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1898	84.4	0	.	p	.	0	I68L	NONSYN	202	204	ATA	521	523	TTA	54;50;50	T;T;A	54;50;48	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	2188	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1898	84.4	0	.	p	.	0	H115Q	NONSYN	343	345	CAC	662	664	CAG	142;143;136	C;A;G	142;141;136	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	2188	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1898	84.4	0	.	p	.	0	D128A	NONSYN	382	384	GAC	701	703	GCC	154;155;159	G;C;C	154;154;159	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	2188	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1898	84.4	0	.	p	.	0	S163A	NONSYN	487	489	TCG	806	808	GCG	127;127;131	G;C;G	125;124;131	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	2188	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1898	84.4	0	.	p	.	0	L231V	NONSYN	691	693	CTT	1010	1012	GTT	99;97;102	G;T;T	77;76;86	.	mdfA;Multidrug translocase MdfA
mdfA.3001328.JQ394987.0_1233.561	mdfA.3001328.JQ394987.0_1233.561	1	0	531	2188	mdfA	1233	1233	97.0	mdfA.l15.c30.ctg.1	1898	84.4	0	.	p	.	0	R285fs	FSHIFT	853	853	C	1172	1172	C	111	C	108	.	mdfA;Multidrug translocase MdfA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	2120	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1954	80.0	0	.	p	.	0	V12trunc	TRUNC	34	34	G	408	408	G	54	G	54	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	2120	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1954	80.0	0	.	p	.	0	R33Q	NONSYN	97	99	CGG	465	467	CAG	60;60;59	C;A;G	58;59;57	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	2120	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1954	80.0	0	.	p	.	0	T83I	NONSYN	247	249	ACC	615	617	ATC	38;37;38	A;T;C	38;37;38	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	2120	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1954	80.0	0	.	p	.	0	I99M	NONSYN	295	297	ATA	663	665	ATG	62;61;61	A;T;G	62;61;61	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	2120	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1954	80.0	0	.	p	.	0	A130T	NONSYN	388	390	GCC	756	758	ACC	82;81;82	A;C;C	82;81;81	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtA.3000792.U00096.2154015_2155263.15	mdtA.3000792.U00096.2154015_2155263.15	1	0	539	2120	mdtA	1248	1248	97.36	mdtA.l15.c4.ctg.1	1954	80.0	0	.	p	.	0	P257T	NONSYN	769	771	CCG	1137	1139	ACG	121;121;118	A;C;G	121;117;117	.	MdtA is the membrane fusion protein of the multidrug efflux complex mdtABC.;mdtA
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	7122	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3793	138.7	0	.	p	.	0	A583T	NONSYN	1747	1749	GCC	2094	2096	ACC	184;184;179	A;C;C	178;181;179	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	7122	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3793	138.7	0	.	p	.	0	K714Q	NONSYN	2140	2142	AAA	2487	2489	CAA	174;174;176	C;A;A	168;172;169	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	7122	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3793	138.7	0	.	p	.	0	N770I	NONSYN	2308	2310	AAT	2655	2657	ATT	135;138;135	A;T;T	134;135;135	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	7122	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3793	138.7	0	.	p	.	0	I798V	NONSYN	2392	2394	ATT	2739	2741	GTT	109;111;109	G,T;T;T	108,1;109;107	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	7122	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3793	138.7	0	.	p	.	0	A834E	NONSYN	2500	2502	GCG	2847	2849	GAG	123;120;121	G;A,C;G,C	123;119,1;119,1	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	7122	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3793	138.7	0	.	p	.	0	L910M	NONSYN	2728	2730	CTG	3075	3077	ATG	131;131;130	A,G;T;G	130,1;131;129	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtB.3000793.U00096.2155262_2158385.215	mdtB.3000793.U00096.2155262_2158385.215	1	0	539	7122	mdtB	3123	3123	98.98	mdtB.l15.c4.ctg.1	3793	138.7	0	.	p	.	0	E955D	NONSYN	2863	2865	GAG	3210	3212	GAT	149;151;152	G;A;T	146;144;148	.	MdtB is a transporter that forms a heteromultimer complex with MdtC to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex.;mdtB
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	6620	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3780	129.4	0	.	p	.	0	I46M	NONSYN	136	138	ATC	485	487	ATG	90;92;92	A,T;T;G	78,2;85;79	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	6620	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3780	129.4	0	.	p	.	0	V208I	NONSYN	622	624	GTC	971	973	ATC	158;160;161	A,G;T;C	151,1;155;159	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	6620	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3780	129.4	0	.	p	.	0	Q980H	NONSYN	2938	2940	CAA	3287	3289	CAC	44;43;44	C;A;C	43;41;42	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtC.3000794.U00096.2158385_2161463.257	mdtC.3000794.U00096.2158385_2161463.257	1	0	539	6620	mdtC	3078	3078	98.64	mdtC.l15.c4.ctg.1	3780	129.4	0	.	p	.	0	P981L	NONSYN	2941	2943	CCC	3290	3292	CTC	44;44;44	C;T;C	43;44;42	.	mdtC;MdtC is a transporter that forms a heteromultimer complex with MdtB to form a multidrug transporter. MdtBC is part of the MdtABC-TolC efflux complex. In the absence of MdtB, MdtC can form a homomultimer complex that results in a functioning efflux complex with a narrower drug specificity.
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	3174	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	2050	113.8	0	.	p	.	0	D3E	NONSYN	7	9	GAT	330	332	GAA	78;77;75	G;A;A	77;77;75	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	3174	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	2050	113.8	0	.	p	.	0	T226A	NONSYN	676	678	ACG	999	1001	GCG	127;125;127	G;C,A;G	127;121,1;126	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	3174	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	2050	113.8	0	.	p	.	0	V340I	NONSYN	1018	1020	GTC	1341	1343	ATC	142;144;151	A,G;T;C	138,1;144;150	.	Efflux pump mdtD;mdtD
mdtD.3001330.U00096.2161463_2162879.299	mdtD.3001330.U00096.2161463_2162879.299	1	0	539	3174	mdtD	1416	1416	98.38	mdtD.l6.c30.ctg.1	2050	113.8	0	.	p	.	0	L441F	NONSYN	1321	1323	TTG	1644	1646	TTT	159;166;173	T;T;T	159;166;173	.	Efflux pump mdtD;mdtD
mdtE.3000795.AP009048.3980025_3981183.753	mdtE.3000795.AP009048.3980025_3981183.753	1	0	27	3560	mdtE	1158	1158	99.31	mdtE.l6.c30.ctg.1	1856	141.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mdtE;MdtE is the membrane fusion protein of the MdtEF multidrug efflux complex. It shares 70% sequence similarity with AcrA.
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	8890	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3682	178.1	0	.	p	.	0	A295T	NONSYN	883	885	GCC	1163	1165	ACC	131;131;126	A;C,A;C	130;128,1;126	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtF.3000796.U00096.3660413_3663527.286	mdtF.3000796.U00096.3660413_3663527.286	1	0	539	8890	mdtF	3114	3114	98.52	mdtF.l15.c4.ctg.1	3682	178.1	0	.	p	.	0	N709D	NONSYN	2125	2127	AAT	2405	2407	GAC	230;228;223	G,A;A;C	224,1;225;222	.	MdtF is the multidrug inner membrane transporter for the MdtEF-TolC efflux complex.;mdtF
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	2818	mdtG	1227	1047	99.33	mdtG.l15.c4.ctg.1	1845	96.7	0	.	p	.	0	V200I	NONSYN	598	600	GTC	779	781	ATC	146;148;147	A;T;C	146;147;146	.	mdtG;Efflux protien mdtG.
mdtG.3001329.NC_007779.1115840_1117067.599	mdtG.3001329.NC_007779.1115840_1117067.599	1	0	513	2818	mdtG	1227	182	99.45	mdtG.l15.c4.ctg.2	702	38.3	0	.	p	.	0	E5G	NONSYN	13	15	GAA	177	179	GGA	36;36;35	G;G;A	35;35;34	.	mdtG;Efflux protien mdtG.
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	2670	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1811	108.7	0	.	p	.	0	G134C	NONSYN	400	402	GGT	730	732	TGT	140;141;139	T;G;T	137;137;134	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	2670	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1811	108.7	0	.	p	.	0	S324L	NONSYN	970	972	TCG	1300	1302	TTG	144;144;144	T;T;G	143;144;144	.	Multidrug resistance protein MdtH;mdtH
mdtH.3001216.U00096.1124117_1125326.120	mdtH.3001216.U00096.1124117_1125326.120	1	0	539	2670	mdtH	1209	1209	98.18	mdtH.l15.c4.ctg.1	1811	108.7	0	.	p	.	0	A394T	NONSYN	1180	1182	GCG	1510	1512	ACG	43;43;41	A;C;G	43;43;41	.	Multidrug resistance protein MdtH;mdtH
mdtL.3001215.U00096.3891614_3892790.621	mdtL.3001215.U00096.3891614_3892790.621	1	0	539	3550	mdtL	1176	1176	98.38	mdtL.l6.c4.ctg.1	1854	140.5	0	.	p	.	0	A185S	NONSYN	553	555	GCC	930	932	TCC	167;169;170	T;C;C	160;167;169	.	Multidrug resistance protein MdtL;mdtL
mdtN.3003548.AP009048.4306556_4307588.3298	mdtN.3003548.AP009048.4306556_4307588.3298	1	0	539	2462	mdtN	1032	1032	98.06	mdtN.l15.c30.ctg.1	1777	102.2	0	.	p	.	0	V119I	NONSYN	355	357	GTT	710	712	ATT	163;164;164	A;T;T	162;163;164	.	mdtN;Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride.
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	4876	mdtO	2052	2052	98.0	mdtO.l15.c30.ctg.1	2697	133.7	0	.	p	.	0	V11M	NONSYN	31	33	GTG	339	341	ATG	78;78;78	A;T;G	78;77;78	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	4876	mdtO	2052	2052	98.0	mdtO.l15.c30.ctg.1	2697	133.7	0	.	p	.	0	T33I	NONSYN	97	99	ACC	405	407	ATC	69;70;74	A;T;C	64;67;74	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	4876	mdtO	2052	2052	98.0	mdtO.l15.c30.ctg.1	2697	133.7	0	.	p	.	0	C116R	NONSYN	346	348	TGC	654	656	CGC	155;151;151	C;G;C,G	153;151;148,1	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	4876	mdtO	2052	2052	98.0	mdtO.l15.c30.ctg.1	2697	133.7	0	.	p	.	0	N238S	NONSYN	712	714	AAC	1020	1022	AGC	158;159;158	A;G;C	156;156;154	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	4876	mdtO	2052	2052	98.0	mdtO.l15.c30.ctg.1	2697	133.7	0	.	p	.	0	M305V	NONSYN	913	915	ATG	1221	1223	GTG	149;151;152	G;T,C;G	149;142,1;151	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	4876	mdtO	2052	2052	98.0	mdtO.l15.c30.ctg.1	2697	133.7	0	.	p	.	0	D326N	NONSYN	976	978	GAC	1284	1286	AAC	94;94;97	A,C;A,C;C	77,1;74,2;87	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	4876	mdtO	2052	2052	98.0	mdtO.l15.c30.ctg.1	2697	133.7	0	.	p	.	0	A341V	NONSYN	1021	1023	GCC	1329	1331	GTC	116;118;118	G;T;C	115;112;116	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	4876	mdtO	2052	2052	98.0	mdtO.l15.c30.ctg.1	2697	133.7	0	.	p	.	0	M351I	NONSYN	1051	1053	ATG	1359	1361	ATA	154;154;149	A;T;A	154;151;148	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	4876	mdtO	2052	2052	98.0	mdtO.l15.c30.ctg.1	2697	133.7	0	.	p	.	0	A387S	NONSYN	1159	1161	GCT	1467	1469	TCT	161;162;161	T;C;T	161;160;160	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	4876	mdtO	2052	2052	98.0	mdtO.l15.c30.ctg.1	2697	133.7	0	.	p	.	0	T516A	NONSYN	1546	1548	ACG	1854	1856	GCG	170;172;169	G;C;G	169;168;169	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	4876	mdtO	2052	2052	98.0	mdtO.l15.c30.ctg.1	2697	133.7	0	.	p	.	0	L587I	NONSYN	1759	1761	CTT	2067	2069	ATC	142;142;144	A;T;C	141;141;144	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtO.3003549.AP009048.4304505_4306557.3300	mdtO.3003549.AP009048.4304505_4306557.3300	1	0	539	4876	mdtO	2052	2052	98.0	mdtO.l15.c30.ctg.1	2697	133.7	0	.	p	.	0	L601Q	NONSYN	1801	1803	CTG	2109	2111	CAG	132;131;133	C;A;G	129;130;133	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtO
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	3150	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	2159	108.4	0	.	p	.	0	S129A	NONSYN	385	387	TCA	734	736	GCG	161;156;148	G;C;G	157;154;147	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	3150	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	2159	108.4	0	.	p	.	0	A187T	NONSYN	559	561	GCC	908	910	ACC	184;188;188	A;C;C	182;186;186	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	3150	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	2159	108.4	0	.	p	.	0	H211R	NONSYN	631	633	CAC	980	982	CGC	167;167;164	C;G;C	166;167;163	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	3150	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	2159	108.4	0	.	p	.	0	V250A	NONSYN	748	750	GTT	1097	1099	GCT	114;110;109	G;C;T	111;109;107	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	3150	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	2159	108.4	0	.	p	.	0	R278K	NONSYN	832	834	AGA	1181	1183	AAA	111;108;108	A;A;A	109;108;104	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	3150	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	2159	108.4	0	.	p	.	0	Q284R	NONSYN	850	852	CAA	1199	1201	CGA	107;108;107	C;G;A	105;107;105	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	3150	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	2159	108.4	0	.	p	.	0	S339A	NONSYN	1015	1017	TCC	1364	1366	GCC	122;116;117	G;C;C	120;115;117	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	3150	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	2159	108.4	0	.	p	.	0	H343D	NONSYN	1027	1029	CAT	1376	1378	GAT	118;122;122	G;A;T	118;120;122	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mdtP.3003550.AP009048.4303042_4304509.3303	mdtP.3003550.AP009048.4303042_4304509.3303	1	0	539	3150	mdtP	1467	1467	97.96	mdtP.l15.c4.ctg.1	2159	108.4	0	.	p	.	0	G482A	NONSYN	1444	1446	GGT	1793	1795	GCT	76;75;76	G;C;T	76;74;71	.	Multidrug resistance efflux pump. Could be involved in resistance to puromycin, acriflavine and tetraphenylarsonium chloride;mdtP
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	8328	mfd	3447	3447	99.16	mfd.l15.c17.ctg.1	3965	155.1	0	.	p	.	0	T437K	NONSYN	1309	1311	ACG	1565	1567	AAG	120;120;119	A;A;G	119;118;119	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mfd.3003844.NC_000913.3.1170517_1173964.3609	mfd.3003844.NC_000913.3.1170517_1173964.3609	1	0	539	8328	mfd	3447	3447	99.16	mfd.l15.c17.ctg.1	3965	155.1	0	.	p	.	0	M796L	NONSYN	2386	2388	ATG	2642	2644	CTG	115;116;116	C;T,C;G	114;111,1;114	.	mfd;mfd dissociates transcription elongation complexes blocked at nonpairing lesions and mediates recruitment of DNA repair proteins. The Mfd (mutation frequency decline) protein, also known as transcription-repair coupling factor, is responsible for ATP-dependent removal of stalled RNA polymerase from DNA lesions by inducing forward movement of the RNA polymerase and subsequent recruitment of nucleotide excision repair machinery to the sites of the lesions.
mgrB.3003820.NC_000913.3.1908622_1908766.3586	mgrB.3003820.NC_000913.3.1908622_1908766.3586	1	0	27	768	mgrB	144	144	100.0	mgrB.l15.c30.ctg.1	1020	56.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	mgrB is a small transmembrane protein produced in the PhoPQ signalling system. It acts as a negative regulator in this system. Inactivation or down-regulation of mgrB confers colistin resistance by absence as shown in Klebsiella pneumoniae;mgrB
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	4780	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2478	142.6	0	.	p	.	0	S278N	NONSYN	832	834	AGC	1244	1246	AAC	144;150;149	A;A;C	144;146;146	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
msbA.3003950.NC_000913.3.966620_968369.3754	msbA.3003950.NC_000913.3.966620_968369.3754	1	0	539	4780	msbA	1749	1749	98.68	msbA.l15.c4.ctg.1	2478	142.6	0	.	p	.	0	M460I	NONSYN	1378	1380	ATG	1790	1792	ATA	210;212;216	A;T;A	209;211;215	.	MsbA is a multidrug resistance transporter homolog from E. coli and belongs to a superfamily of transporters that contain an adenosine triphosphate (ATP) binding cassette (ABC) which is also called a nucleotide-binding domain (NBD). MsbA is a member of the MDR-ABC transporter group by sequence homology. MsbA transports lipid A, a major component of the bacterial outer cell membrane, and is the only bacterial ABC transporter that is essential for cell viability.;msbA
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	3754	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1968	140.8	1	SNP	p	D369N	0	.	.	1105	1107	GAT	1397	1399	GAT	220;219;218	G;A;T	217;214;213	murA.3003775.CP009072.1414817_1416077.3548:1:1:D369N:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
murA.3003775.CP009072.1414817_1416077.3548	murA.3003775.CP009072.1414817_1416077.3548	1	1	27	3754	murA_12	1260	1260	98.49	murA_12.l15.c4.ctg.1	1968	140.8	1	SNP	p	L370I	0	.	.	1108	1110	CTG	1400	1402	CTG	222;216;217	C;T;G	221;215;214	murA.3003775.CP009072.1414817_1416077.3548:1:1:L370I:.:murA or UDP-N-acetylglucosamine enolpyruvyl transferase catalyses the initial step in peptidoglycan biosynthesis and is inhibited by fosfomycin. Overexpression of murA through mutations such as Asp369Asn and Leu370Ile confers fosfomycin resistance. Extensive evidence has shown the significance of C115 mutations in conferring fosfomycin resistance since this residue represents a primary binding site for the antibiotic across many species.	Escherichia coli mutant murA conferring resistance to fosfomycin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1582	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1390	83.6	0	.	p	.	0	R27C	NONSYN	79	81	CGT	443	445	TGT	134;133;127	T;G;T	131;130;126	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1582	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1390	83.6	0	.	p	.	0	I117T	NONSYN	349	351	ATC	713	715	ACC	120;121;121	A,G;C;C	115,1;120;118	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1582	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1390	83.6	0	.	p	.	0	G187D	NONSYN	559	561	GGC	923	925	GAC	96;96;96	G;A;C,A,T	95;94;94,1,1	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1582	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1390	83.6	0	.	p	.	0	Y199N	NONSYN	595	597	TAT	959	961	AAT	91;92;92	A;A;T	90;91;91	.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1582	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1390	83.6	1	SNP	p	R15C	0	.	.	43	45	CGC	407	409	CGC	184;182;183	C;G;C	182;181;183	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R15C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1582	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1390	83.6	1	SNP	p	S33R	0	.	.	97	99	AGC	461	463	AGC	137;137;136	A;G;C	135;132;134	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:S33R:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1582	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1390	83.6	1	SNP	p	G131D	0	.	.	391	393	GGC	755	757	GGC	114;112;115	G;G;C	114;110;111	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:G131D:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1582	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1390	83.6	1	SNP	p	R203L	0	.	.	607	609	CGT	971	973	CGT	95;91;91	C;G;T	95;90;91	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203L:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
nfsA.3003751.NC_000913.3.891183_891906.3520	nfsA.3003751.NC_000913.3.891183_891906.3520	1	1	539	1582	nfsA	723	723	98.89	nfsA.l15.c4.ctg.1	1390	83.6	1	SNP	p	R203C	0	.	.	607	609	CGT	971	973	CGT	95;91;91	C;G;T	95;90;91	nfsA.3003751.NC_000913.3.891183_891906.3520:1:1:R203C:.:nfsA encodes the major oxygen-insesitive nitroreductase in E. coli. The first step of resistance to nitrofurazone is mutation of nfsA.	Escherichia coli nfsA mutations conferring resistance to nitrofurantoin
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	3398	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1732	145.3	0	.	p	.	0	D312E	NONSYN	934	936	GAT	1229	1231	GAG	215;213;213	G;A;G	213;211;210	.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	3398	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1732	145.3	1	SNP	p	G141D	0	.	.	421	423	GGT	716	718	GGT	226;219;215	G;G;T	226;219;214	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	3398	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1732	145.3	1	SNP	p	G141E	0	.	.	421	423	GGT	716	718	GGT	226;219;215	G;G;T	226;219;214	ompF.3003390.NC_007779.986315_987404.2075:1:1:G141E:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	3398	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1732	145.3	1	SNP	p	R154A	0	.	.	460	462	CGT	755	757	CGT	208;209;210	C;G;T	206;209;208	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154A:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
ompF.3003390.NC_007779.986315_987404.2075	ompF.3003390.NC_007779.986315_987404.2075	1	1	539	3398	ompF	1089	1089	99.91	ompF.l15.c4.ctg.1	1732	145.3	1	SNP	p	R154D	0	.	.	460	462	CGT	755	757	CGT	208;209;210	C;G;T	206;209;208	ompF.3003390.NC_007779.986315_987404.2075:1:1:R154D:.:Mutant forms of the Escherichia coli outer membrane porin OmpF result in reduced permeability to antibiotics.	Escherichia coli ompF mutants
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	6658	parC_2	2259	2259	99.16	parC_2.l15.c4.ctg.1	2926	168.4	0	.	p	.	0	A533V	NONSYN	1597	1599	GCG	1941	1943	GTG	225;224;224	G;T,C;G	224;219,1;222	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	6658	parC_2	2259	2259	99.16	parC_2.l15.c4.ctg.1	2926	168.4	0	.	p	.	0	P542S	NONSYN	1624	1626	CCG	1968	1970	TCG	228;242;247	T;C;G	209;232;239	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	6658	parC_2	2259	2259	99.16	parC_2.l15.c4.ctg.1	2926	168.4	0	.	p	.	0	S747N	NONSYN	2239	2241	AGC	2583	2585	AAC	119;117;118	A;A;C	118;115;116	.	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	6658	parC_2	2259	2259	99.16	parC_2.l15.c4.ctg.1	2926	168.4	1	SNP	p	A85T	0	.	.	253	255	GCG	597	599	GCG	161;162;160	G;C;G	160;158;159	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:A85T:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	6658	parC_2	2259	2259	99.16	parC_2.l15.c4.ctg.1	2926	168.4	1	SNP	p	D111H	0	.	.	331	333	GAT	675	677	GAT	179;179;178	G,C;A;T	177,1;173;175	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:D111H:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parC.3003941.NC_004337.2.3159154_3161413.3742	parC.3003941.NC_004337.2.3159154_3161413.3742	1	1	539	6658	parC_2	2259	2259	99.16	parC_2.l15.c4.ctg.1	2926	168.4	1	SNP	p	S129P	0	.	.	385	387	TCC	729	731	TCC	168;170;168	T;C;C	164;169;165	parC.3003941.NC_004337.2.3159154_3161413.3742:1:1:S129P:.:Point mutation in parC conferring resistance to fluoroquinolone antibiotics in Shigella flexneri,	Shigella flexneri parC conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	4574	parE_1	1893	1893	97.52	parE_1.l15.c4.ctg.1	2492	134.8	0	.	p	.	0	D473N	NONSYN	1417	1419	GAC	1698	1700	AAC	182;182;186	A;A;C	180;182;185	.	Escherichia coli parE conferring resistance to fluoroquinolones
parE.3003316.NC_007779.3172159_3174052.2073	parE.3003316.NC_007779.3172159_3174052.2073	1	1	539	4574	parE_1	1893	1893	97.52	parE_1.l15.c4.ctg.1	2492	134.8	1	SNP	p	D476N	0	.	.	1426	1428	GAT	1707	1709	GAT	196;199;205	G;A;T	196;196;202	parE.3003316.NC_007779.3172159_3174052.2073:1:1:D476N:.:Point mutation in Escherichia coli parE resulting in fluoroquinolones resistance	Escherichia coli parE conferring resistance to fluoroquinolones
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	4078	patA	1380	1380	99.78	patA.l6.c30.ctg.1	2073	144.8	0	.	p	.	0	P202Q	NONSYN	604	606	CCG	945	947	CAG	199;204;202	C;A;G	197;202;199	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
patA.3000024.NC_000913.3.3219493_3220873.3692	patA.3000024.NC_000913.3.3219493_3220873.3692	1	0	539	4078	patA	1380	1380	99.78	patA.l6.c30.ctg.1	2073	144.8	0	.	p	.	0	E360D	NONSYN	1078	1080	GAG	1419	1421	GAT	186;188;187	G;A;T	183;183;183	.	PatA is an ABC transporter of Streptococcus pneumoniae that interacts with PatB to confer fluoroquinolone resistance.;patA
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	11998	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4649	190.9	1	SNP	p	V146F	0	.	.	436	438	GTT	758	760	GTT	217;218;219	G;T,G;T	213;214,1;215	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:V146F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	11998	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4649	190.9	1	SNP	p	Q513P	0	.	.	1537	1539	CAG	1859	1861	CAG	178;184;183	C;A;G	177;180;180	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	11998	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4649	190.9	1	SNP	p	Q513L	0	.	.	1537	1539	CAG	1859	1861	CAG	178;184;183	C;A;G	177;180;180	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:Q513L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	11998	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4649	190.9	1	SNP	p	H526Y	0	.	.	1576	1578	CAC	1898	1900	CAC	206;207;208	C;A;C	205;205;206	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:H526Y:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	11998	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4649	190.9	1	SNP	p	R529S	0	.	.	1585	1587	CGT	1907	1909	CGT	217;210;212	C,A;G;T	215,1;210;210	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529S:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	11998	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4649	190.9	1	SNP	p	R529C	0	.	.	1585	1587	CGT	1907	1909	CGT	217;210;212	C,A;G;T	215,1;210;210	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R529C:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	11998	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4649	190.9	1	SNP	p	S531F	0	.	.	1591	1593	TCC	1913	1915	TCC	205;202;198	T,C;C;C	200,1;200;198	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:S531F:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	11998	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4649	190.9	1	SNP	p	L533P	0	.	.	1597	1599	CTC	1919	1921	CTC	197;200;201	C;T;C	195;196;199	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:L533P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	11998	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4649	190.9	1	SNP	p	T563P	0	.	.	1687	1689	ACC	2009	2011	ACC	220;217;218	A,G;C;C	214,1;215;218	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:T563P:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	11998	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4649	190.9	1	SNP	p	P564L	0	.	.	1690	1692	CCT	2012	2014	CCT	221;228;231	C;C;T	220;228;231	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:P564L:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rpoB.3003288.NC_002695.4990140_4994169.2096	rpoB.3003288.NC_002695.4990140_4994169.2096	1	1	27	11998	rpoB	4029	4029	99.03	rpoB.l15.c4.ctg.1	4649	190.9	1	SNP	p	R687H	0	.	.	2059	2061	CGT	2381	2383	CGT	251;253;247	C,G;G;T	249,1;251;244	rpoB.3003288.NC_002695.4990140_4994169.2096:1:1:R687H:.:Point mutations that occurs in Escherichia coli rpoB resulting in resistance to rifampicin	Escherichia coli rpoB mutants conferring resistance to rifampicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.1	517	1285.2	1	SNP	n	A1519C	0	.	.	1519	1519	A	481	481	A	842	A	830	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.1	517	1285.2	1	SNP	n	A1519T	0	.	.	1519	1519	A	481	481	A	842	A	830	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	504	100.0	rrsB+.l15.c17.ctg.1	517	1285.2	1	SNP	n	A1519G	0	.	.	1519	1519	A	481	481	A	842	A	830	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A1519G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1092	1248.8	0	.	n	.	0	A226G	SNP	226	226	A	317	317	G	1375	G,T	1368,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1092	1248.8	1	SNP	n	A794G	0	.	.	794	794	A	885	885	A	1322	A,C,G	1276,1,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794G:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1092	1248.8	1	SNP	n	A794T	0	.	.	794	794	A	885	885	A	1322	A,C,G	1276,1,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:A794T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1092	1248.8	1	SNP	n	G926C	0	.	.	926	926	G	1017	1017	G	1004	G,C	994,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926C:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1092	1248.8	1	SNP	n	G926T	0	.	.	926	926	G	1017	1017	G	1004	G,C	994,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926T:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1092	1248.8	1	SNP	n	G926A	0	.	.	926	926	G	1017	1017	G	1004	G,C	994,1	rrsC.3003333.U00096.3941808_3943349.3229:0:0:G926A:.:Point mutations in the 3' minor, 3' major, and central domains in the rrsC 16S rRNA gene of Escherichia coli can confer resistance to kasugamicin	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1092	1248.8	0	HET	.	.	.	C680T	.	680	680	C	771	771	C	1368	C,T	1153,203	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1092	1248.8	0	HET	.	.	.	A79G	.	79	79	A	170	170	A	1485	A,G	1100,369	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1092	1248.8	0	HET	.	.	.	C719T	.	719	719	C	810	810	C	1246	C,T	715,521	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1092	1248.8	0	HET	.	.	.	T273A,G,C	.	273	273	T	364	364	T	1295	T,A,G,C	915,364,1,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1092	1248.8	0	HET	.	.	.	C183T,A	.	183	183	C	274	274	C	1242	C,T,A	849,383,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1092	1248.8	0	HET	.	.	.	T90C	.	90	90	T	181	181	T	1399	T,C	1050,337	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1092	1248.8	0	HET	.	.	.	A250T	.	250	250	A	341	341	A	1273	A,T	946,312	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1092	1248.8	0	HET	.	.	.	G474A,C	.	474	474	G	565	565	G	1314	G,A,C	967,333,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1092	1248.8	0	HET	.	.	.	A253T	.	253	253	A	344	344	A	1289	A,T	950,305	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	1001	99.9	rrsB+.l15.c17.ctg.2	1092	1248.8	0	HET	.	.	.	C194T	.	194	194	C	285	285	C	1301	C,T	1040,239	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	185	100.0	rrsB+.l15.c17.ctg.3	185	345.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	181	96.15	rrsB+.l15.c17.ctg.5	181	230.2	0	.	n	.	0	G1002A	SNP	1002	1002	G	76	76	A	357	A	355	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	181	96.15	rrsB+.l15.c17.ctg.5	181	230.2	0	.	n	.	0	G1006C	SNP	1006	1006	G	80	80	C	365	C	363	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	181	96.15	rrsB+.l15.c17.ctg.5	181	230.2	0	.	n	.	0	T1010C	SNP	1010	1010	T	84	84	C	365	C	362	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	181	96.15	rrsB+.l15.c17.ctg.5	181	230.2	0	.	n	.	0	A1019.	DEL	1019	1019	A	92	92	G	376	G	375	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	181	96.15	rrsB+.l15.c17.ctg.5	181	230.2	0	.	n	.	0	.1023G	INS	1023	1023	T	97	97	G	373	G,C	369,1	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
rrsC.3003333.U00096.3941808_3943349.3229	rrsC.3003333.U00096.3941808_3943349.3229	0	0	677	32668	rrsB+	1542	181	96.15	rrsB+.l15.c17.ctg.5	181	230.2	0	.	n	.	0	C1038T	SNP	1038	1038	C	112	112	T	359	T	353	.	Escherichia coli 16S rRNA mutation in the rrsC gene conferring resistance to kasugamicin
sat_1.3002895.AB211124.0_525.584	sat_1.3002895.AB211124.0_525.584	1	0	27	1670	sat_1	525	525	100.0	sat_1.l15.c4.ctg.1	1283	95.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	sat-1;sat-1 is a plasmid-mediated streptothricin acetyltransferase in Escherichia coli
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	1362	soxR	465	465	100.0	soxR.l15.c17.ctg.1	1087	93.3	1	SNP	p	R20H	0	.	.	58	60	CGC	396	398	CGC	148;156;162	C;G;C	143;155;161	soxR.3003381.U00096.4277468_4277933.2074:1:1:R20H:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxR.3003381.U00096.4277468_4277933.2074	soxR.3003381.U00096.4277468_4277933.2074	1	1	27	1362	soxR	465	465	100.0	soxR.l15.c17.ctg.1	1087	93.3	1	SNP	p	G121D	0	.	.	361	363	GGT	699	701	GGT	186;187;187	G;G;T	186;186;187	soxR.3003381.U00096.4277468_4277933.2074:1:1:G121D:.:SoxR is a sensory protein that upregulates soxS expression in the presence of redox-cycling drugs. This stress response leads to the expression many multidrug efflux pumps.	Escherichia coli soxR mutants
soxS.3003511.NC_000913.4277059_4277383.3528	soxS.3003511.NC_000913.4277059_4277383.3528	1	1	27	1222	soxS_1	324	324	99.69	soxS_1.l6.c30.ctg.1	1092	83.6	1	SNP	p	A12S	0	.	.	34	36	GCA	390	392	GCA	202;208;210	G;C;A	202;208;209	soxS.3003511.NC_000913.4277059_4277383.3528:1:1:A12S:.:SoxS is a global regulator that up-regulates the expression of AcrAB efflux genes. It also reduces OmpF expression to decrease cell membrane permeability.	Escherichia coli soxS mutant
strA.manually_added_NC_009345_WP_001082319.1_6656_7459	strA.manually_added_NC_009345_WP_001082319.1_6656_7459	1	0	16	18	APH_3____Ib+	804	199	100.0	APH_3____Ib+.l15.c30.ctg.1	199	1.9	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	sul2.manually_added_NC_009345_WP_001043267.1_5780_6595	1	0	27	1572	sul2	816	816	100.0	sul2.l15.c4.ctg.1	1570	73.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetA.3000165.NC_020418.458865_460071.275	tetA.3000165.NC_020418.458865_460071.275	1	0	539	3216	tet-	1206	1206	99.92	tet-.l15.c30.ctg.1	1952	121.8	0	.	p	.	0	T171A	NONSYN	511	513	ACT	911	913	GCT	175;178;178	G;C;T	174;175;178	.	TetA is a tetracycline efflux pump found in many species of Gram-negative bacteria.;tetA
tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	tetA.manually_added_NC_009345_WP_000804063.1_1230_2429	1	0	16	78	tetA	1200	183	100.0	tetA.l6.c4.ctg.2	185	2.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tetC.manually_added_J01830_AAB59095.1_2926_3519	tetC.manually_added_J01830_AAB59095.1_2926_3519	1	0	539	1050	tetC	594	594	99.66	tetC.l15.c4.ctg.1	1201	64.5	0	.	p	.	0	S152D	NONSYN	454	456	AGT	785	787	GAT	97;93;93	G;A;T	97;92;92	.	Original ref seq: J01830.1 Transposon Tn10 tetracycline resistance and repressor genes tetA and tetR, complete cds
tetD.3000168.BX664015.204137_204554.417	tetD.3000168.BX664015.204137_204554.417	1	0	27	1074	tetD	417	417	100.0	tetD.l15.c4.ctg.1	1116	70.4	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	TetD is a tetracycline efflux pump found exclusively in Gram-negative bacteria.;tetD
tetR.3003479.AL513383.179218_179845.2090	tetR.3003479.AL513383.179218_179845.2090	1	1	27	1730	tetR_2	627	627	100.0	tetR_2.l15.c30.ctg.1	1281	100.0	1	SNP	p	H64Y	0	.	.	190	192	CAC	521	523	CAC	143;145;142	C;A;C	142;143;142	tetR.3003479.AL513383.179218_179845.2090:1:1:H64Y:.:TetR is the repressor of the tetracycline resistance element; its N-terminal region forms a helix-turn-helix structure and binds DNA. Binding of tetracycline to TetR reduces the repressor affinity for the tetracycline resistance gene (tetA) promoter operator sites. Mutations arise within tetR results in lower affinity for tetracyclin	tetR
tetR.3003479.AL513383.179218_179845.2090	tetR.3003479.AL513383.179218_179845.2090	1	1	27	1730	tetR_2	627	627	100.0	tetR_2.l15.c30.ctg.1	1281	100.0	1	SNP	p	N82H	0	.	.	244	246	AAT	575	577	AAT	170;171;172	A;A;T	170;170;172	tetR.3003479.AL513383.179218_179845.2090:1:1:N82H:.:TetR is the repressor of the tetracycline resistance element; its N-terminal region forms a helix-turn-helix structure and binds DNA. Binding of tetracycline to TetR reduces the repressor affinity for the tetracycline resistance gene (tetA) promoter operator sites. Mutations arise within tetR results in lower affinity for tetracyclin	tetR
tetR.manually_added_J01830_AAB59093.1_903_1526	tetR.manually_added_J01830_AAB59093.1_903_1526	1	0	27	1730	tetR_1	624	624	100.0	tetR_1.l15.c30.ctg.1	1281	100.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: J01830.1 Transposon Tn10 tetracycline resistance and repressor genes tetA and tetR, complete cds
tetR.manually_added_NC_009345_WP_000164043.1_474_1124	tetR.manually_added_NC_009345_WP_000164043.1_474_1124	1	0	16	18	tetR	651	343	100.0	tetR.l6.c4.ctg.1	343	2.0	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	Original ref seq: NC_009345.1 Shigella sonnei Ss046 plasmid pSS046_spA, complete sequence
tolC.3000237.FJ768952.0_1488.563	tolC.3000237.FJ768952.0_1488.563	1	0	27	4388	tolC	1488	1488	98.72	tolC.l6.c17.ctg.1	2154	151.1	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	tolC;TolC is a protein subunit of many multidrug efflux complexes in Gram negative bacteria. It is an outer membrane efflux protein and is constitutively open. Regulation of efflux activity is often at its periplasmic entrance by other components of the efflux complex.
